Table 2.
Clinical characteristics and outcomes of children and adolescents with community acquired pneumonia
| Variables | n/N (%) |
|---|---|
| Cough | 513/525 (97.7) |
| Productive | 322/513 (62.7) |
| Fever | 485/525 (92.4) |
| Dyspnea | 398/525 (75.8) |
| Tachypneaa | 256/518 (49.4) |
| Irritability | 240/525 (45.7) |
| Somnolence | 214/525 (40.8) |
| Diarrhea | 135/525 (25.7) |
| Earache | 50/525 (9.5) |
| Oxygen saturation < 90% at the time of hospital admission | 176/453 (38.9) |
| Severity of community acquired pneumonia | |
| Non severe | 376/525 (71.6) |
| Severe | 130/525 (24.8) |
| Very severe | 19/525 (3.6) |
| Complications | 32/524 (6.1) |
| Pleural effusion | 22/524 (4.2) |
| Acute respiratory distress syndrome | 13/524 (2.5) |
| Empyema | 11/523 (2.1) |
| Lung abscess | 3/524 (0.6) |
| Acute renal disease | 1/524 (0.2) |
| Length of stay in days, median (IQR) | 4 (3–6) |
| Admission to intensive care unit | 22/524 (4.2) |
| Mortality | 0/525 (0.0) |
a ≥60 breath/min for children younger than 2 months; ≥50 for children between 2 to 11 months; ≥40 children between 1 to 5 years; ≥30 between 5 to 12 years; and > 20 for children older than 12 years